series-c-plus
Stage
2
Investors
About
BIOMx develops natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot infections and osteomyelitis.
Explore BIOMx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.